Grants and Contributions:
Title:
Development of a Novel Nasal Cannula Device to Improve Portable Oxygen Therapy
Agreement Number:
1042382
Agreement Value:
$145,600.00
Agreement Date:
May 1, 2026 - Apr 30, 2027
Description:
Pulmvita Inc. is an Edmonton-based medical device company developing a novel nasal cannula to improve the reliability and efficiency of portable oxygen therapy. The device uses proprietary breath-detection technology and a nasal pillows seal to ensure consistent oxygen delivery during various activities, including sleep and exercise. Firm intends to build its own quality management system (QMS), submit regulatory approvals, and complete the design transfer for manufacturing.
Organization:
National Research Council Canada
Expected Results:
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Location:
Ardrossan, Alberta, CA T8G 2C3
Reference Number:
172-2026-2027-Q1-1042382
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
773635305
Recipient Type:
For-profit organization
Recipient's Legal Name:
Pulmvita Inc.
Federal Riding Name:
Sherwood Park--Fort Saskatchewan
Federal Riding Number:
48032
Program:
Industrial Research Assistance Program
Program Purpose:
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Coverage:
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity.
NAICS Code:
541710